Medical Press

Patients with moderate dementia received infusions of Egb 761 or placebo for 4 days a week, for 4 weeks. Ginkgo patients scored significantly better on measures of daily living, illness symptoms, and depression than did the placebo group. The authors found ginkgo superior to placebo for behavioral, psychopathologic, and psychometric planes. [Hasse et al. (1996)]

Reference:
Freedman, Lynda W, PhD et al. Best Practices in Compelmentary and Alternative Medicine. Maryland: Aspen Publishers, 2001.

Below are a few studies to show the efficacy of S. John’s Wort (hypericum) on depression: Continue Reading »

From AHC Media, LLC

Depression is a common, chronic, and costly medical condition. The World Health Organization identified major depression as the fourth leading cause of worldwide disease in 1990, resulting in more disability than either ischemic heart disease or cerebrovascular disease.(1) In the United States, depression’s impact on disability is comparable to that of heart disease.(2) In addition, depression is associated with a heightened incidence of physical symptoms, such as pain and increased functional impairment.(3) Furthermore, post-myocardial infarction depression is an independent risk factor for increased mortality.(4) Continue Reading »